Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized,Single-Blind, Placebo-controlled, Self-matched Pairing, Independent Evaluated Study to Evaluate the Efficacy and Safety of RGN-137 Topical Gel in Subjects With Junctional and Dystrophic Epidermolysis Bullosa (CELEB)

NCT03578029 is registered in ClinicalTrials.gov with Lenus Therapeutics, LLC as lead sponsor.

NCT NCT03578029
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03578029 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized,Single-Blind, Placebo-controlled, Self-matched Pairing, Independent Evaluated Study to Evaluate the Efficacy and Safety of RGN-137 Topical Gel in Subjects With Junctional and Dystrophic Epidermolysis Bullosa (CELEB)
Lead sponsor
Lenus Therapeutics, LLC
Phase
Phase 2
Overall status
Terminated
Start date
May 22, 2019
Completion date
November 23, 2021
Enrollment
4 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

dystrophic epidermolysis bullosa, junctional epidermolysis bullosa